International Psoriasis Council

Advancing Knowledge. Improving Care.

Advancing Knowledge. Improving Care.

Introducing IPC’s Newest Councilors

Please join us in warmly welcoming Daniela Armijo, Ncoza Dlova, Benjamín Hidalgo Matlock, and Wilson Liao as IPC’s newest Councilors for 2023. Their appointment by the IPC Board of Directors in June is a testament to their unwavering dedication to psoriasis and their commitment to enhancing patient care for individuals worldwide affected by this condition.

As esteemed IPC Councilors, these experts will play a crucial role as trusted advisors, offering their invaluable global expertise in psoriasis research, treatment, and education. Their immense support will strengthen all IPC programs, events, and initiatives, ensuring we continue to make significant strides in the field.

To gain deeper insights into the backgrounds of our newest Councilors, we encourage you to read their comprehensive biographies. By doing so, you will discover the wealth of knowledge and experience they bring. We are confident that their contributions will significantly aid us in fulfilling our mission of advancing psoriasis care globally.

We are thrilled to have Daniela Armijo, Ncoza Dlova, Benjamín Hidalgo Matlock, and Wilson Liao join our esteemed community of IPC Councilors. Together, we will continue positively impacting and driving progress in psoriasis care worldwide.

Daniela Armijo, MD

Clínica Dermacross

Santiago, Chile

Bio

Ncoza Noxolo Dlova, MD, PhD

University of KwaZulu Natal

Durban, South Africa

Bio

Benjamin Hidalgo Matlock, MD

Skin Care Physicians of Costa Rica

San Jose, Costa Rica

Bio

Wilson Liao, MD

University of California San Francisco

San Francisco, California, United States

Bio

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Categories

Recent Posts

New IPC Guidelines on Generalized Pustular Psoriasis

Commentary: An Oral Interleukin-23-Receptor Antagonist Peptide for Plaque Psoriasis

Introducing our Latest IPC Councilors: Experts in Psoriasis Treatment and Research

Also Read

Generalized Pustular Psoriasis

New IPC Guidelines on Generalized Pustular Psoriasis

Learn about the new global diagnostic criteria for Generalized Pustular Psoriasis as set by the International Psoriasis Council. Discover the essential features, the importance of accurate diagnosis, and the expected global impact on patient care.

Read More

Subscribe to the IPC Newsletter

Stay up-to-date on the latest research, news, and upcoming events right in your inbox.